Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.485, 2005-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
IV valproic acid reduces headache pain in patients with moderate-to-severe headache or migraine
Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. :
Access to resources
Recommend
Spotlight on Rizatriptan in Migraine
CNS Drugs, Vol. 16, Iss. 10, 2002-01 ,pp. :
Emerging drugs for moderate-to-severe psoriasis
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. :
An Economic Evaluation of Rizatriptan in the Treatment of Migraine
PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. :
Ustekinumab useful for moderate-to-severe plaque psoriasis
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :